Lord, Abbett & Co
DVAX

Lord, Abbett & Co’s Dynavax Technologies DVAX Stock Holding History

Lord, Abbett & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-362,826
Closed -$5.53M – 837
2018
Q2 		$5.53M Buy
362,826
+74,908
+26% +$1.29M 0.02% 727
2018
Q1 		$5.71M Sell
287,918
-229,232
-44% -$3.96M 0.02% 703
2017
Q4 		$9.67M Sell
517,150
-234,051
-31% -$4.7M 0.03% 623
2017
Q3 		$16.2M Sell
751,201
-54,719
-7% -$866K 0.05% 522
2017
Q2 		$7.78M Buy
+805,920
New +$5.23M 0.02% 685
2016
Q3 		– Sell
-273,362
Closed -$3.98M – 883
2016
Q2 		$3.98M Buy
273,362
+76,747
+39% +$1.31M 0.01% 756
2016
Q1 		$3.78M Sell
196,615
-38,653
-16% -$781K 0.01% 756
2015
Q4 		$5.68M Buy
235,268
+10,505
+5% +$263K 0.02% 705
2015
Q3 		$5.51M Buy
+224,763
New +$6.36M 0.02% 713

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Lord, Abbett & Co's DVAX Position: Q3 2018 in Review

Lord, Abbett & Co sold out of Dynavax Technologies (DVAX) in Q3 2018, closing a stake of 362,826 shares — an estimated $5.53M sold.

Lord, Abbett & Co first reported a position in DVAX in Q3 2015 and held it in 9 quarters. The position peaked at $16.2M in Q3 2017. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • Lord, Abbett & Co reported no remaining Dynavax Technologies position as of Q3 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 362,826 Dynavax Technologies shares in Q3 2018, an estimated $5.53M.
  • Lord, Abbett & Co first reported a position in Dynavax Technologies in Q3 2015 and held it in 9 quarters.
  • Lord, Abbett & Co's Dynavax Technologies position peaked at $16.2M in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on Lord, Abbett & Co's 13F filing for Q3 2018, filed 14 Nov 2018.